Study: NCT04583241

Intervention type: OTHER
Intervention: Constitution of serum bank at D0
Description: Blood samples at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: Constitution of serum bank at D0
Description: Blood samples at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: Constitution of serum bank at D0
Description: Blood samples at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: Constitution of serum bank at D0
Description: Blood samples at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: Constitution of serum bank during follow-up
Description: Blood samples are obtained at week 2, week 6 post-surgery, at the end of antibiotherapy and 6 months post-surgery, only for patients with staphylococcus aureus monoinfection who are follow-up during two years.

Intervention type: OTHER
Intervention: ELISA assays of serum markers of bone remodeling at D0
Description: Assessment by ELISA assays of serum markers of bone remodelling: the osteocalcin (OC), the procollagen propeptide type 1 (PINP), the cross linked telopeptide of type 1 collagen (CTX1) and the periostin at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: ELISA assays of serum markers of bone remodeling at D0
Description: Assessment by ELISA assays of serum markers of bone remodelling: the osteocalcin (OC), the procollagen propeptide type 1 (PINP), the cross linked telopeptide of type 1 collagen (CTX1) and the periostin at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: ELISA assays of serum markers of bone remodeling at D0
Description: Assessment by ELISA assays of serum markers of bone remodelling: the osteocalcin (OC), the procollagen propeptide type 1 (PINP), the cross linked telopeptide of type 1 collagen (CTX1) and the periostin at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: ELISA assays of serum markers of bone remodeling at D0
Description: Assessment by ELISA assays of serum markers of bone remodelling: the osteocalcin (OC), the procollagen propeptide type 1 (PINP), the cross linked telopeptide of type 1 collagen (CTX1) and the periostin at Day 0 (day of surgery)

Intervention type: OTHER
Intervention: ELISA assays of serum markers of bone remodeling during follow-up
Description: Assessment by ELISA assays of serum markers of bone remodelling: the osteocalcin (OC), the procollagen propeptide type 1 (PINP), the cross linked telopeptide of type 1 collagen (CTX1) and the periostin at week 2, week 6 post-surgery, at the end of antibiotherapy and 6 months post-surgery, only for patients with staphylococcus aureus monoinfection who are follow-up during two years

Intervention type: OTHER
Intervention: Analysis of bacterial gene expression at D0
Description: Assessement of bacterial gene expression on surgery residual tissue (bone tissue, joint fluid, fragment of prostheses) collected at Day 0 (day of the surgery)

Intervention type: OTHER
Intervention: Analysis of bacterial gene expression at D0
Description: Assessement of bacterial gene expression on surgery residual tissue (bone tissue, joint fluid, fragment of prostheses) collected at Day 0 (day of the surgery)

Intervention type: OTHER
Intervention: Analysis of bacterial gene expression at D0
Description: Assessement of bacterial gene expression on surgery residual tissue (bone tissue, joint fluid, fragment of prostheses) collected at Day 0 (day of the surgery)

Intervention type: OTHER
Intervention: Analysis of bacterial gene expression at D0
Description: Assessement of bacterial gene expression on surgery residual tissue (bone tissue, joint fluid, fragment of prostheses) collected at Day 0 (day of the surgery)